Biodance Collagen Gel Toner Pads by Biodance
Biodance

Biodance Collagen Gel Toner Pads

Toners

Safety score

Pregnancy-focused assessment

Low Risk79/100
Higher concernLower concern

One or more ingredients have a low-risk flag in MamaSkin's current assessment. Review the notes and your own circumstances.

Formula and assessment check

Ingredient safety review updated 17 June 2026. Product formulas can change, so compare the ingredients shown here with the packaging you have.

Report a formula mismatch

Ingredient breakdown

See how the listed formula falls across MamaSkin's pregnancy-focused risk bands.

22

No known risks

3

Low risk

0

Medium risk

0

High risk

Ingredients

Ingredients with a higher risk flag appear first, followed by the rest of the formula.

Sh-Oligopeptide-1

Low Risk

Recombinant human oligopeptide cosmetic ingredient used in topical growth-factor-style formulas, commonly associated with EGF-style skin-conditioning claims. Normal topical cosmetic use is not currently treated as a known pregnancy-restricted concern, and these larger signaling peptides are expected to have limited intact-skin penetration. Pregnancy- and breastfeeding-specific cosmetic data are limited, so MamaSkin scores this conservatively as low risk rather than no known risks. This assessment applies to topical cosmetic products only, not injectable growth-factor treatments, microneedling serums, wound use, or oral supplements.

Sources: Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. https://doi.org/10.3390/cosmetics4020016; Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25-34; dermatology reviews on topical growth factors and skin rejuvenation; EU CosIng / INCI cosmetic ingredient references.

Sh-Polypeptide-1

Low Risk

Recombinant human polypeptide cosmetic ingredient used in topical growth-factor-style skin-conditioning formulas. Normal topical cosmetic use is not currently treated as a known pregnancy-restricted concern, and large peptide/protein ingredients are expected to have limited intact-skin penetration. Pregnancy- and breastfeeding-specific cosmetic data are limited, so MamaSkin scores this conservatively as low risk rather than no known risks. This assessment applies to topical cosmetic products only, not injectable growth-factor treatments, microneedling serums, wound use, or oral supplements.

Sources: Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. https://doi.org/10.3390/cosmetics4020016; Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25-34; dermatology reviews on topical growth factors and skin rejuvenation; EU CosIng / INCI cosmetic ingredient references.

Sh-Oligopeptide-2

Low Risk

Recombinant human oligopeptide cosmetic ingredient used in topical growth-factor-style skin-conditioning formulas. Normal topical cosmetic use is not currently treated as a known pregnancy-restricted concern, but pregnancy- and breastfeeding-specific cosmetic data are limited. Because this ingredient is biologically framed as a signaling peptide rather than a simple cosmetic conditioning peptide, MamaSkin scores it conservatively as low risk. This assessment applies to topical cosmetic products only, not injectable growth-factor treatments, microneedling serums, wound use, or oral supplements.

Sources: Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. https://doi.org/10.3390/cosmetics4020016; Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25-34; dermatology reviews on topical growth factors and skin rejuvenation; EU CosIng / INCI cosmetic ingredient references.

Show all (25)

Water

No Known Risks

Collagen Water

No Known Risks

Butylene Glycol

No Known Risks

Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

1,2-Hexanediol

No Known Risks

1,2-Hexanediol is commonly used as a solvent and preservative booster; topical exposure is low and it has no known pregnancy or breastfeeding concerns at cosmetic concentrations, though very sensitive skin may occasionally react.

Sources: CIR; EU/UK Cosmetics Regulation

Polyglyceryl-10 Laurate

No Known Risks

Polyglycerin fatty-acid ester used as an emulsifier and solubilizer. Reviewed cosmetic safety references do not identify a pregnancy- or breastfeeding-specific concern for normal topical cosmetic use.

Sources: CIR cosmetic ingredient safety references for polyglyceryl fatty acid esters; EU CosIng / cosmetics regulatory inventory

Glycerin

No Known Risks

Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Ethylhexylglycerin

No Known Risks

Preservative booster and skin-conditioning agent. Considered safe for cosmetic use with low systemic exposure when used as intended.

Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)

Arginine

No Known Risks

Amino acid used as a humectant, skin-conditioning agent, and pH-adjusting support ingredient. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.

Sources: CIR: Safety Assessment of α-Amino Acids as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Allantoin

No Known Risks

Allantoin is a soothing skin protectant commonly used to help reduce irritation and support comfort, with no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Carbomer

No Known Risks

Polymer thickener used to create gel textures. Large-molecule ingredient with negligible systemic absorption.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Xanthan Gum

No Known Risks

Natural polysaccharide thickener used for stability and texture. Not associated with pregnancy-specific concerns.

Sources: European cosmetics regulatory framework

Disodium EDTA

No Known Risks

Disodium EDTA is a chelating agent used to improve formula stability and performance; it is considered low concern in topical cosmetic use, with no known pregnancy or breastfeeding risks at typical concentrations.

Sources: CIR; EU/UK Cosmetics Regulation

Sodium Polyacrylate

No Known Risks

Polymer used for texture and absorbency. Large-molecule ingredient with low systemic exposure.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Cyanocobalamin

No Known Risks

Palmitoyl Tripeptide-5

No Known Risks

Synthetic signal peptide used in topical cosmetic anti-aging and skin-conditioning formulas. Reviewed cosmetic peptide literature lists palmitoyl tripeptide-5 among topically used matricin-style peptides. No pregnancy- or breastfeeding-specific risk signal was identified for normal topical cosmetic use.

Sources: Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. doi:10.3390/cosmetics4020016; EU CosIng / INCI cosmetic ingredient references.

Hydrolyzed Hyaluronic Acid

No Known Risks

Humectant and skin-conditioning ingredient in the hyaluronate family. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.

Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Collagen Extract

No Known Risks

Hydrolyzed Elastin

No Known Risks

A structural protein or hydrolysed peptide used for skin or hair conditioning. Cosmetic safety reviewers concluded that the assessed skin and connective-tissue-derived proteins are safe in current practices, subject to appropriate animal-source and impurity controls. Protein sensitivity remains possible.

Sources: CIR: Safety Assessment of Skin and Connective Tissue-Derived Proteins and Peptides as Used in Cosmetics https://www.cir-safety.org/sites/default/files/tsupep092017final.pdf

Galactomyces Ferment Filtrate

No Known Risks

A yeast-derived ferment, filtrate or extract used for skin conditioning. Cosmetic safety reviewers concluded that cosmetic ingredients derived from the reviewed yeast species are safe in current practices; this record applies to the standardized cosmetic INCI material, not an unspecified live culture.

Sources: CIR: Yeast-derived ingredients final assessment, June 2024; Galactomyces Ferment Filtrate conclusion; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf

Hyaluronic Acid

No Known Risks

High-water-binding humectant used to support hydration at the skin surface. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.

Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Sh-Polypeptide-22

No Known Risks

Sh-Polypeptide-3

No Known Risks

Formulations can change without notice. For the most accurate result, compare this list with your packaging and scan the exact ingredient label in MamaSkin when you repurchase.

How to use this assessment

The risk band is the primary conclusion. The score adds detail within that band and should not be used to compare products as if a one-point difference were clinically meaningful.

MamaSkin provides pregnancy-focused information, not medical advice. Your midwife, GP, pharmacist or dermatologist should take priority when your circumstances differ from typical cosmetic use.

Read the full methodology